title: Aspirin for primary prevention of coronary heart disease.
abstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the effects, both harmful and beneficial of aspirin in the primary prevention of coronary heart disease.
  Does aspirin prevent fatal and non-fatal CHD in people without symptomatic vascular disease? Does aspirin reduce all-cause and cardiovascular mortality?
  Are the effects of aspirin, be they harmful or beneficial, affected by underlying risk of CHD? Do the major adverse effects of Aspirin ever outweigh its benefit and is this balance affected by underlying CHD risk?
authors.affiliation: Clinical Pharmacology and Therapeutics, Royal Hallamshire Hospital, Sheffield, UK.
authors.forename: Peter Pr
authors.initials: PP
authors.lastname: Jackson
authors.affiliation: Department of Epidemiology & Population, c/o Cochrane Heart Group, London, UK.
authors.forename: Mohsen
authors.initials: M
authors.lastname: Aarabi
authors.affiliation: Clinical Pharmacology and Therapeutics, Royal Hallamshire Hospital, Sheffield, UK.
authors.forename: Erica
authors.initials: E
authors.lastname: Wallis